Skip header and navigation

13 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR EOC
February 4, 2022 What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines? EOC220103 RR EOC
October 29, 2021 Long COVID: What does it mean for the healthcare system and programs to deal with it? EOC021901v2 RR EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 13, 2021 What are the outcomes of ECMO and COVID, particularly in small centers? EOC011101 RR EOC
November 25, 2020 Are probiotics effective for prevention or therapy of respiratory tract infections in all ages? EOC111201 RR EOC
November 2, 2020 What is the risk of reinfection from COVID-19? [Update] EOC032401v3 RR EOC
September 29, 2020 What is the evidence that runny nose or sneezing are symptoms of COVID-19? EOC092401 RR EOC
May 22, 2020 In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation? EOC052102 RR EOC
May 11, 2020 What percentage of COVID-19 patients have hyposmia or anosmia? EOC033102 RR EOC
April 7, 2020 What is the prevalence of sore throat as a symptom of COVID-19? EOC040201 RR EOC

13 records – page 1 of 1.